Intimation Regarding Appointment of Secretarial Auditor of the Company at 18th Annual General Meeting held on 30th September, 2025
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Shelter Pharma Ltd informed the BSE that shareholders at its 18th Annual General Meeting on September 30, 2025 approved the appointment of M/s. Murtuza Mandorwala & Associates, Practicing Company Secretaries based in Ahmedabad, as the company's Secretarial Auditor. The appointment is for a term of five consecutive years, from the conclusion of the 18th AGM until the conclusion of the 23rd AGM in 2030. The appointment was made under Section 204 of the Companies Act, 2013 and SEBI LODR Regulations. No reason for change was disclosed as it is a fresh appointment. The filing was signed by Managing Director Mustaqim Nisar Ahmed Sabugar.
This is a routine regulatory compliance filing with no material impact on the stock price or shareholders. The appointment of a secretarial auditor for a five-year term is standard corporate governance practice required under Indian law and does not signal any governance concerns or changes in the company's management.